1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. HEART TEST LABORATORIES INC

Heart Test Laboratories Inc

XNAS: HSCS

Download real time

2.91 0.01 (0.34%)

78.44% Fall from 52W High

5,128 XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
9S
12W
2O
2T
3.1

Market Cap

Low in industry
-0.4

PE TTM

Negative PE TTM
0

PEG TTM

0.7

Price to Book

Low in industry
-0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for Heart Test Laboratories Inc

The latest disclosure was made by Mark T. Hilz in Heart Test Laboratories Inc where a trade of 45,000 Employee Stock Option (Right to Buy) done was reported to US exchanges on Jan. 16, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mark T. Hilz Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 45,000 45,000 - - Employee Stock Option (Right to Buy)
David R. Wells Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 6,000 6,000 - - Employee Stock Option (Right to Buy)
Andrew Simpson Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 45,000 45,000 - - Employee Stock Option (Right to Buy)
Danielle Watson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 9,000 9,000 - - Employee Stock Option (Right to Buy)
Brian Szymczak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 6,000 6,000 - - Employee Stock Option (Right to Buy)
Bruce Bent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 6,000 6,000 - - Employee Stock Option (Right to Buy)
Andrew Simpson Director, See Remarks Other type of transaction at price $ 0.00 per share. 12 Aug 2024 17 7,629 - - Common Stock, $0.001 par value
Mark T. Hilz Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 300,000 300,000 - - Employee Stock Option (Right to Buy)
David R. Wells Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 50,000 50,000 - - Director Stock Option (Right to Buy)
Andrew Simpson Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 300,000 300,000 - - Employee Stock Option (Right to Buy)
Danielle Watson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 75,000 75,000 - - Employee Stock Option (Right to Buy)
Bruce Bent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 50,000 50,000 - - Director Stock Option (Right to Buy)
Brian Szymczak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 50,000 50,000 - - Director Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters